BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31195865)

  • 1. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
    Howell MP; Smith AM; Lindsay EB; Drury SS
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
    Syvertsen JL; Toneff H; Madden DR; Clapp JD
    Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids affect the fetal brain: reframing the detoxification debate.
    Caritis SN; Panigrahy A
    Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Management in Pregnancy and Postpartum.
    Brown HL
    Obstet Gynecol Clin North Am; 2020 Sep; 47(3):421-427. PubMed ID: 32762927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
    Schroeder M; White J
    S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
    Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
    J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous Care Pathway to Patient Opioid Abstinence: Should All Programs Offer this Approach?
    Patel A; Dietz P; Casto A; DePond J; Taylor L; Seybold D; Blake A; Calhoun B
    Issues Law Med; 2021; 36(2):193-210. PubMed ID: 36629776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 20. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.